Infections caused by carbapenem-resistant Acinetobacter spp. are considered an urgent public health problem. Antibiotic options are scarce but new drugs may be available in the near future. We will discuss this important topic with experts in the field.
Guests:
Dr. Yohei Doi, Professor and Director, Center for Innovative Antimicrobial Therapy, University of Pittsburgh Medical Center, Pittsburgh, PA
Dr. Joseph Patrick Hornak. Fellow, Infectious Diseases, University of Texas Medical Branch, Galveston, TX
👍 Subscribe to ASM's KZitem channel at goo.gl/mOVHlK
🔬 Learn more about the American Society for Microbiology at www.asm.org
✅ Become a member today at www.asmscience.org/join
📱 Join us on social:
Facebook: / asmfan
Twitter: / asmicrobiology
Instagram: / asmicrobiology
Негізгі бет Ғылым және технология Treatment of Acinetobacter spp. infections
Пікірлер: 7